Detalles de la búsqueda
1.
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
Haematologica;
106(4): 978-986, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32327504
2.
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.
Blood Cancer Discov;
5(2): 106-113, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194367
3.
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.
Transplant Cell Ther;
28(12): 829.e1-829.e8, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174934
4.
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel.
Cancer Med;
10(6): 1936-1943, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641257
5.
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma.
Blood Adv;
4(14): 3268-3276, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702097
6.
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel.
Clin Cancer Res;
26(18): 4823-4831, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669372
7.
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities.
BioDrugs;
33(1): 45-60, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30560413
8.
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin's lymphoma.
Ther Clin Risk Manag;
14: 1007-1017, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29910620
9.
Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL.
Blood Adv;
6(13): 3970-3973, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35816359
10.
Regulatory challenges and considerations for the clinical application of CAR T cell therapy.
Expert Opin Biol Ther;
21(5): 549-552, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555927
Resultados
1 -
10
de 10
1
Próxima >
>>